176.
Messerli P.M. Arterielle Hypertonie, liksventrikulare Hypertrophie
und plotzlicher Herzld / F.M. Messerli., R.E. Schmieder//Dtscli. mod. V.schr.
- P. 1682-1687.
177.
Muller N. Pulmonary tymphangiomyomatosis -correlation of CT with
radiographic and functional findings / N. Muller, C. Chiles, P. Kulning. Ra
diology. - 1990. - V. 175. - P. 535-539.
178.
Murciano D. A randomized, controlled trial of theophylline m patients
with severe chronic obstructive pulmonary disease / D. Murciano N Engl j
Med. - 1989. - V. 320. - P. 1521-1525.
179.
Paggiaro P.L. Multicentre randomized placebocontrolled trial of in
haled fluticasone propionate in patients with chronic obstructive pulmonary
disease / P.L. Paggiaro // Lancet. - 1998. •- V. 351. - P. 773-780.
180.
Parish R. Adverse effects of angiotensin converting enzyme
(ACE)inhibitors / R. Parish., L. Mi ller// Drug Saf. - 1992. - V. 7, - P. 14-3 I
181.
Peter A. van Zwieten, Csaba Farsang. Эффективная комбинация
двух и более антигипертензивных препаратов. Рекомендации Европей
ского общества по изучению гипертонии. Обзоры клинической кардио
логии №1, 2005.
182.
Petty T.L. Controversial indications for long-term respiratory care:
long-term oxygen therapy / T.L Petty /VMonaldi Arch Chest Dis. - 1999. V
54. - P. 58- 60.
183.
Pickering T. Recommendations for the use home (self) and ambulato
ryblood pressure monitoring / T. Pickering. // Amer. J. Elypertens. - 1996. - V.
9. -P. 1-11.
184.
Physiologic relevance of T-type calcium-ion channels: potential indica
tions for T-type calcium antagonists / K. Hermsmeyer, S. Mishra, K. Miya-
gama, R. Minshall / /Cl in Tlier. - 1997. - V. 19. - P. 18-26.
185
Qing F. Pulmonary angiotensin-converting enzyme (ACE) binding and
inhibition in humans. A positron emission tomography study E. Qing, T.J.
